Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2

Status

Completed 4Unknown 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Thoracic 1

Conditions

Prostatic Neoplasms 3Lung Cancer Metastatic 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × regramostim × Clear all
NCT03113851 2023-06-13

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

Peking University Cancer Hospital & Institute

Phase 2 Completed
40 enrolled
Thoracic

Lung Cancer Metastatic

NCT01706458 2021-06-18

Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer

University of Wisconsin, Madison

Phase 2 Completed
18 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT01341652 2021-01-20

Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer

University of Wisconsin, Madison

Phase 2 Completed
99 enrolled 15 charts
Genitourinary

Prostatic Neoplasms

NCT00849121 2019-11-21

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

University of Wisconsin, Madison

Phase 2 Completed
17 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡